A look at the top drug delivery stocks; Nanotech may be the future, but what are its risks?;

 @DamianFierce: The coming onslaught of blockbuster knockoffs could be a huge opportunity for drug delivery firms. News | Follow @DamianFierce

> Valeant Pharmaceuticals ($VRX) leads a list of the highest-performing drug delivery stocks, compiled by Benzinga. Report

> Medical News Today takes a closer look at the rise of nanotechnological treatments and their possible risk factors. Story

> Apricus Biosciences ($APRI) is heading toward commercialization in Canada for Femprox, which uses its patented transdermal delivery cream. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.